Independent Pilot Research Survey Demonstrates Else Products Dramatically Improved Major Feeding Related Disorders & Symptoms in Large Majority of Children
18 Noviembre 2021 - 9:45AM
ELSE NUTRITION HOLDINGS INC.
(BABY.V)
(BABYF)
(0YL.F) ("Else" or the
"Company") the Plant-Based baby, toddler and
children nutrition company, is pleased to announce highly favorable
results from an independent pilot study conducted with U.S. mom
customers of its Plant-Based Nutrition for Toddlers and Kids.
- Conducted independently by third
party global market research firm, GetWizer, the study revealed
over three quarters of Parents whose children suffered from
gastrointestinal problems (vomiting, reflux, spit ups) whilst using
another formula or supplement, reported these symptoms improved
after using Else Toddler or Else Kids
- The pilot study reveals major
improvement in disorders and symptoms related to feeding problems
such as:
- Weight gain – poor weight gain and
growth problem was resolved in over 82% of the cases
- GI related symptoms (spit up,
vomit, etc) – were improved in over 85% and about half of them
reported significant to 100% complete improvement
- Bowel movements were improved in
over 79% of the cases and almost 100% reported change in stool
consistency from too hard or too loose to a more “normal”
stool
- Rash symptoms were improved in over
86% (improvement was reported in severity, frequency and length of
symptoms)
“These results are extremely encouraging and
provide independent validation as to the potentially significant
difference clean label, whole plant food-based Else products are
making with children across the country,” stated Hamutal Yitzhak,
CEO and Co-Founder of Else Nutrition. “Improving lives and
providing a real alternative to dairy for early childhood nutrition
was the spark for starting Else and it is reassuring to see
validation from moms that Else products are truly helping to make
their families’ lives better,” she added.
The pilot study indicated top reported reasons
for starting the child on Else Drink were: 1. Plant-Based diet or
healthy lifestyle; 2. Else products natural ingredients; 3. To help
address a clinical condition (i.e. food sensitivities, allergies,
etc.)
Additionally, 75% chose Else based on
plant-based/healthy lifestyle and preferred ingredients and 25% to
address medical reasons such as poor growth, intolerances and
allergies. Over 70% of the kids loved the taste and are happy and
enjoy drinking it and 97% of parents intend to continue giving
their child Else nutritional products. Of those surveyed, 90% of
parents said they would recommend using Else products to their
friends.
The GetWizer pilot study was independently
conducted via electronic, online survey among randomly selected
customers using Else Plant-Based Nutrition for Toddlers and Kids.
The survey will now be expanded to more mothers to ensure a larger
sample size.
About GetWizer
GetWizer provides the technology framework for
consumer-centric organizations. The company integrates consumer
intelligence into both tactical and strategic product and marketing
decision-making at scale. GetWizer's unique technology is
easily tailored. The company provides a complete solution for
preparing, analyzing and visualizing consumer data.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food
and nutrition company focused on developing innovative, clean and
plant-based food and nutrition products for infants, toddlers,
children, and adults. Its revolutionary, plant-based, non-soy,
formula is a clean-ingredient alternative to dairy-based formula.
Else Nutrition (formerly INDI) won the "2017 Best Health and Diet
Solutions" award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently
ranked as the #1 Top seller in the baby and toddler formula
category on Amazon. The holding company, Else Nutrition Holdings
Inc., is a publicly traded company, listed as TSX Venture Exchange
under the trading symbol BABY and is quoted on the US OTC Markets
QX board under the trading symbol BABYF and on the Frankfurt
Exchange under the symbol 0YL. Else's Executives include
leaders hailing from leading infant nutrition companies. Many
of Else advisory board members had past executive roles in
companies such as Mead Johnson, Abbott Nutrition, Plum Organics and
leading infant nutrition Societies, and some of them currently
serve in different roles in leading medical centers and academic
institutes such as Boston Children's Hospital, Pediatrics at
Harvard Medical School, USA, Tel Aviv University, Schneider
Children's Medical Center of Israel, Rambam Medical Center and
Technion, Israel and University Hospital Brussels, Belgium.
For more information,
visit: elsenutrition.com or @elsenutrition on Facebook
and Instagram.
Media ContactErin JundefBrilliant
PRErinj@brilliantprm.com
For more information, contact:Mrs. Hamutal
Yitzhak, CEO, Co-Founder & DirectorELSE Nutrition Holdings
Inc.E: hamutaly@elsenutrition.comP: +972(0)3-6445095
Mr. Sokhie Puar, Lead Director of Else
NutritionEmail: sokhiep@elsenutrition.comP :
604-603-7787
US Investor Relations Contact:
Lytham Partners, LLCMr. Ben ShamsianNew York |
PhoenixE: shamsian@lythampartners.comP: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the Company’s financial disclosure documents. Such
forward-looking statements reflect current estimates, beliefs and
assumptions, which are based on management’s perception of current
conditions and expected future developments, as well as other
factors management believes are appropriate in the circumstances.
No assurance can be given that the foregoing will prove to be
correct. Forward-looking statements made in this press release
assume, among others, the expectation that there will be no
interruptions or supply chain failures as a result of COVID 19 and
that the manufacturing, broker and supply logistic agreement with
the Company do not terminate. Actual results may differ from the
estimates, beliefs and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management’s expectations only as of the date of this press
release. The Company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Else Nutrition (TSXV:BABY)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Else Nutrition (TSXV:BABY)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024